Argue with an Academic: Yuan Qiong Hu on Access to Medication

The year of 2015 marked the 20th anniversary of the Agreement on Trade-Related Intellectual Property Rights (TRIPS) under the auspices of the World Trade Organisation (WTO). TRIPS came into being and faced controversies since its early years. The impact of TRIPS on access to medicines and innovation has triggered international activism and resistance, especially from developing countries. Essentially, medicines that were once excluded from patent protection in many countries are now subject to patenting as required by TRIPS. Continue reading “Argue with an Academic: Yuan Qiong Hu on Access to Medication”

Health Diplomacy: A Path to a Better Model

In our increasingly globalised world, health is no longer an internal issue; it needs to be examined through a host of different lenses. Governments invest a lot of money in health, ranging from richer countries such as Canada with universal healthcare provision, to India with state-provided public health to the opposite end of the spectrum in places like Angola, where there is effectively no state healthcare provision. Add to this the effect of health outcomes in countries near and far, and the issue escalates from local to global pretty quickly. Today, departments of defence, labour, and even tourism have a stake in the global health profile. Continue reading “Health Diplomacy: A Path to a Better Model”